These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

758 related articles for article (PubMed ID: 30359560)

  • 41. CRISPR/Cas9, the Powerful New Genome-Editing Tool for Putative Therapeutics in Obesity.
    Franco-Tormo MJ; Salas-Crisostomo M; Rocha NB; Budde H; Machado S; Murillo-Rodríguez E
    J Mol Neurosci; 2018 May; 65(1):10-16. PubMed ID: 29732484
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases.
    Kuruvilla J; Sasmita AO; Ling APK
    Neurol Sci; 2018 Nov; 39(11):1827-1835. PubMed ID: 30076486
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High efficient multisites genome editing in allotetraploid cotton (Gossypium hirsutum) using CRISPR/Cas9 system.
    Wang P; Zhang J; Sun L; Ma Y; Xu J; Liang S; Deng J; Tan J; Zhang Q; Tu L; Daniell H; Jin S; Zhang X
    Plant Biotechnol J; 2018 Jan; 16(1):137-150. PubMed ID: 28499063
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum.
    Liu J; Wang Y; Lu Y; Zheng P; Sun J; Ma Y
    Microb Cell Fact; 2017 Nov; 16(1):205. PubMed ID: 29145843
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The CRISPR/Cas9 system produces specific and homozygous targeted gene editing in rice in one generation.
    Zhang H; Zhang J; Wei P; Zhang B; Gou F; Feng Z; Mao Y; Yang L; Zhang H; Xu N; Zhu JK
    Plant Biotechnol J; 2014 Aug; 12(6):797-807. PubMed ID: 24854982
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Versatile CRISPR/Cas9-mediated mosaic analysis by gRNA-induced crossing-over for unmodified genomes.
    Allen SE; Koreman GT; Sarkar A; Wang B; Wolfner MF; Han C
    PLoS Biol; 2021 Jan; 19(1):e3001061. PubMed ID: 33444322
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [CRISPR-Cas system as molecular scissors for gene therapy].
    Heinz GA; Mashreghi MF
    Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CRISPR/Cas9-mediated correction of human genetic disease.
    Men K; Duan X; He Z; Yang Y; Yao S; Wei Y
    Sci China Life Sci; 2017 May; 60(5):447-457. PubMed ID: 28534256
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CRISPR-Cas9-mediated genome editing in apple and grapevine.
    Osakabe Y; Liang Z; Ren C; Nishitani C; Osakabe K; Wada M; Komori S; Malnoy M; Velasco R; Poli M; Jung MH; Koo OJ; Viola R; Nagamangala Kanchiswamy C
    Nat Protoc; 2018 Dec; 13(12):2844-2863. PubMed ID: 30390050
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis.
    Hong KQ; Liu DY; Chen T; Wang ZW
    World J Microbiol Biotechnol; 2018 Sep; 34(10):153. PubMed ID: 30269229
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genome Editing by CRISPR/Cas9 in Sorghum Through Biolistic Bombardment.
    Liu G; Li J; Godwin ID
    Methods Mol Biol; 2019; 1931():169-183. PubMed ID: 30652290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induced mutation and epigenetics modification in plants for crop improvement by targeting CRISPR/Cas9 technology.
    Khan MHU; Khan SU; Muhammad A; Hu L; Yang Y; Fan C
    J Cell Physiol; 2018 Jun; 233(6):4578-4594. PubMed ID: 29194606
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The CRISPR-Cas system: beyond genome editing].
    Croteau FR; Rousseau GM; Moineau S
    Med Sci (Paris); 2018 Oct; 34(10):813-819. PubMed ID: 30451675
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CRISPR/Cas9 Platforms for Genome Editing in Plants: Developments and Applications.
    Ma X; Zhu Q; Chen Y; Liu YG
    Mol Plant; 2016 Jul; 9(7):961-74. PubMed ID: 27108381
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Timing of CRISPR/Cas9-related mRNA microinjection after activation as an important factor affecting genome editing efficiency in porcine oocytes.
    Sato M; Kosuke M; Koriyama M; Inada E; Saitoh I; Ohtsuka M; Nakamura S; Sakurai T; Watanabe S; Miyoshi K
    Theriogenology; 2018 Mar; 108():29-38. PubMed ID: 29195121
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between somatic mosaicism of Pax6 mutation and variable developmental eye abnormalities-an analysis of CRISPR genome-edited mouse embryos.
    Yasue A; Kono H; Habuta M; Bando T; Sato K; Inoue J; Oyadomari S; Noji S; Tanaka E; Ohuchi H
    Sci Rep; 2017 Mar; 7(1):53. PubMed ID: 28246397
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pervasive Genotypic Mosaicism in Founder Mice Derived from Genome Editing through Pronuclear Injection.
    Oliver D; Yuan S; McSwiggin H; Yan W
    PLoS One; 2015; 10(6):e0129457. PubMed ID: 26053263
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of a genome editing technique using the CRISPR/Cas9 system in the industrial filamentous fungus Aspergillus oryzae.
    Katayama T; Tanaka Y; Okabe T; Nakamura H; Fujii W; Kitamoto K; Maruyama J
    Biotechnol Lett; 2016 Apr; 38(4):637-42. PubMed ID: 26687199
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Somatic mosaicism and allele complexity induced by CRISPR/Cas9 RNA injections in mouse zygotes.
    Yen ST; Zhang M; Deng JM; Usman SJ; Smith CN; Parker-Thornburg J; Swinton PG; Martin JF; Behringer RR
    Dev Biol; 2014 Sep; 393(1):3-9. PubMed ID: 24984260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.